plumbagin has been researched along with Schistosoma mansoni Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coelho, LCBB; da Silva, AM; de Araújo, HDA; de Azevedo Albuquerque, MCP; de Lima Aires, A; De Melo, AMMA; Diniz, EGM; França, WWM; Pereira, DR; Silva, HAMF | 1 |
| Abdel-Latif, M; Abuelsaad, ASA; Allam, GA; Bakery, HH; Elkenawy, AE; Khalil, RG | 1 |
2 other study(ies) available for plumbagin and Schistosoma mansoni Infection
| Article | Year |
|---|---|
Toxic, cytotoxic and genotoxic effect of plumbagin in the developmental stages of Biomphalaria glabrata (Say, 1818-intermediate host) and cercaricidal activity against the infectious agent of schistosomiasis mansoni.
Topics: Animals; Biomphalaria; DNA Damage; Humans; Naphthoquinones; Schistosomiasis mansoni | 2022 |
Anti-inflammatory, antioxidant, anti-fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents; Antioxidants; Catalase; Female; Granuloma; Immunoglobulin G; Interleukin-10; Interleukin-13; Interleukin-17; Interleukin-4; Liver; Male; Mice; Naphthoquinones; Praziquantel; Schistosoma mansoni; Schistosomiasis; Schistosomiasis mansoni; Schistosomicides; Sulfhydryl Compounds; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2022 |